AltRegen
PrivateLast Round
Series A
Nov 19, 2018
Company Overview
AltRegen is a biotechnology company that develops therapeutic interventions for age-related macular degeneration (AMD) by targeting the biophysical properties of Bruch's membrane.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AltRegen Comparables
Compare AltRegen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breye Therapeutics | 80% | |
| Guangzhou Yinming Biomedical Technology | 78% | |
| Character Biosciences | 77% | |
AltRegen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 19, 2018 |
AltRegen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kite Entrepreneurship Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2018
Raised Series A led by Kite Entrepreneurship Foundation.
AltRegen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AltRegen's valuation, stock price, and market status.